A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V

被引:65
作者
Chun, BJDH [1 ]
Dunner, DL [1 ]
机构
[1] Univ Washington, Dept Psychiat & Behav Sci, Ctr Anxiety & Depress, Seattle, WA 98105 USA
关键词
antidepressants; bipolar disorder; depression; hypomania;
D O I
10.1046/j.1399-5618.2003.00084.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine if the classification of 'antidepressant-induced hypomania' in DSM-IV is supported by available data. Methods: We reviewed the available scientific literature to examine the incidence of mania and hypomania in non-bipolar patients who were treated with antidepressants. Results: Eighty-nine per cent of studies of antidepressants in major depressive disorder patients reported no cases of treatment-induced hypomania. No instances of treatment-induced hypomania were reported in three large studies of patients with chronic forms of depression. Conclusions: The rate of antidepressant-induced hypomania in major depressive disorder is within the rate of misdiagnosis of bipolar depression as unipolar. Depressed patients who experience antidepressant-associated hypomania are truly bipolar.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 136 条
[1]   DOUBLE-BLIND-STUDY OF THE EFFICACY AND SAFETY OF SERTRALINE VERSUS FLUOXETINE IN MAJOR DEPRESSION [J].
AGUGLIA, E ;
CASACCHIA, M ;
CASSANO, GB ;
FARAVELLI, C ;
FERRARI, G ;
GIORDANO, P ;
PANCHERI, P ;
RAVIZZA, L ;
TRABUCCHI, M ;
BOLINO, F ;
SCARPATO, A ;
BERARDI, D ;
PROVENZANO, G ;
BRUGNOLI, R ;
ROZZINI, R .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 (03) :197-202
[2]  
AKISKAL HS, 1987, PSYCHOPHARMACOL BULL, V23, P68
[3]   Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders [J].
Akiskal, HS ;
Bourgeois, ML ;
Angst, J ;
Post, R ;
Möller, HJ ;
Hirschfeld, R .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 59 :S5-S30
[4]  
AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114
[5]  
Amsterdam JD, 2000, J AFFECT DISORDERS, V59, P225, DOI 10.1016/S0165-0327(99)00149-4
[6]   Efficacy and safety of fluoxetine in treating bipolar II major depressive episode [J].
Amsterdam, JD ;
Garcia-España, F ;
Fawcett, J ;
Quitkin, FM ;
Reimherr, FW ;
Rosenbaum, JF ;
Schweizer, E ;
Beasley, C .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :435-440
[8]   CONTROLLED COMPARISON OF NEFAZODONE AND AMITRIPTYLINE IN MAJOR DEPRESSIVE INPATIENTS [J].
ANSSEAU, M ;
DARIMONT, P ;
LECOQ, A ;
DENAYER, A ;
EVRARD, JL ;
KREMER, P ;
DEVOITILLE, JM ;
DIERICK, M ;
MERTENS, C ;
MESOTTEN, F ;
MIREL, J ;
TROISFONTAINES, B ;
VANMOFFAERT, M ;
VANBRABANT, E .
PSYCHOPHARMACOLOGY, 1994, 115 (1-2) :254-260
[9]   A COMPARISON OF MOCLOBEMIDE, AMITRIPTYLINE AND PLACEBO IN DEPRESSION - A CANADIAN MULTICENTER STUDY [J].
BAKISH, D ;
BRADWEJN, J ;
NAIR, N ;
MCCLURE, J ;
REMICK, R ;
BULGER, L .
PSYCHOPHARMACOLOGY, 1992, 106 :S98-S101
[10]  
Baldwin DS, 1996, J CLIN PSYCHIAT, V57, P46